TrialProceedings of the National Academy of Sciences of the United States of America2000

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer.

E Mueller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.